Latest News for: lir

Edit

LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories

ACCESSWIRE 06 Feb 2026
VANCOUVER, BC / ACCESS Newswire / February 5, 2026 / LIR Life Sciences Corp ... The Project Phase 2 program is designed to explore a series of synthetic variants derived from LIR's lead protamine-based sequences ... About LIR Life Sciences Corp.
Edit

LIRS Extends Deadline for Filing Annual Returns to Feb. 7

This Day 31 Jan 2026
The Lagos State Internal Revenue Service (LIRS) has extended the deadline for filing of employers’ annual tax returns by one week, from February 1 to February 7, 2026. In a statement issued yesterday, the Executive Chairman of LIRS, Dr.
Edit

Mary White obituary: Cofounder of Lir Chocolates and former senator

The Irish Times 31 Jan 2026
She and Connie Doody founded Lir Chocolates in 1987, taking it from a standing start to a company valued at several million when it was sold to British group Zetar 20 years later.
Edit

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies

Pharmiweb 30 Jan 2026
VANCOUVER, BC / ACCESS Newswire / January 29, 2026 / LIR Life Sciences Corp ... These interim results provide preliminary in vivo support for LIR's CPP-enabled transdermal platform for GLP/GIP-based therapies ... About LIR Life Sciences Corp.
Edit

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled ...

ACCESSWIRE 30 Jan 2026
VANCOUVER, BC / ACCESS Newswire / January 29, 2026 / LIR Life Sciences Corp ... These interim results provide preliminary in vivo support for LIR's CPP-enabled transdermal platform for GLP/GIP-based therapies ... About LIR Life Sciences Corp.
Edit

LIRS: 98% of Workers’ll Pay Less or Zero Tax Under New Regime

This Day 26 Jan 2026
The Lagos State Internal Revenue Service (LIRS), has said that under Nigeria’s new tax regime, only 1.6 per cent of Lagos taxpayers will face higher tax bills, while about 98 per cent of workers will either pay less or nothing at all.
Edit

LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents ...

ACCESSWIRE 23 Jan 2026
VANCOUVER, BC / ACCESS Newswire / January 22, 2026 / LIR Life Sciences Corp ... Completion of the design phase allows LIR to proceed towards formal study execution, which is expected to occur in Q1, 2026 ... ON BEHALF OF LIR LIFE SCIENCES CORP.,.
Edit

LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules

Pharmiweb 22 Jan 2026
VANCOUVER, BC / ACCESS Newswire / January 22, 2026 / LIR Life Sciences Corp ... Completion of the design phase allows LIR to proceed towards formal study execution, which is expected to occur in Q1, 2026 ... ON BEHALF OF LIR LIFE SCIENCES CORP.,.
Edit

LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based ...

ACCESSWIRE 16 Jan 2026
VANCOUVER, BC / ACCESS Newswire / January 15, 2026 / LIR Life Sciences Corp ... This in vivo study represents an important next step towards advancing LIR's transdermal platform from design-stage planning into functional testing in a small animal model.
Edit

LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform

ACCESSWIRE 09 Jan 2026
VANCOUVER, BC / ACCESS Newswire / January 8, 2026 / LIR Life Sciences Corp ... For LIR, this engagement of Neuland is intended to further preclinical evaluation and inform future clinical and commercial planning ... About LIR Life Sciences Corp.
Edit

LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor

ACCESSWIRE 19 Dec 2025
VANCOUVER, BC / ACCESS Newswire / December 18, 2025 / LIR Life Sciences Corp ... A41QA9) ("LIR" or the "Company") is pleased to announce that Dr ... Singer will contribute to LIR's strategy for expanding access to affordable obesity treatments globally.
Edit

LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies

ACCESSWIRE 12 Dec 2025
VANCOUVER, BC / ACCESS Newswire / December 11, 2025 / LIR Life Sciences Corp ... The filing is intended to protect LIR's approach to delivering these therapies through the skin, with the goal of replacing or reducing the need for injections.
×